Associations Between Cessation of Second-Line Therapies and Relapse Rates of Childhood Refractory Minimal-Change Nephrotic Syndrome: A Single-Center, Retrospective Chart Review
Authors:
Open Access
- 12 April 2022
- journal article
- review article
- Published by Elsevier in Current Therapeutic Research
- Vol. 96, 100671
Abstract
No abstract availableKeywords
Funding Information
- Health and Family Planning Commission of Sichuan Province
- Shanghai Municipal Commission of Health and Family Planning (201640193)
This publication has 23 references indexed in Scilit:
- Second-Line Immunosuppressive Treatment of Childhood Nephrotic Syndrome: A Single-Center ExperienceNephron Extra, 2014
- Treatment with tacrolimus and prednisolone is preferable to intravenous cyclophosphamide as the initial therapy for children with steroid-resistant nephrotic syndromeKidney International, 2012
- Treatment of steroid-sensitive nephrotic syndrome: new guidelines from KDIGOPediatric Nephrology, 2012
- New therapies in steroid-sensitive and steroid-resistant idiopathic nephrotic syndromePediatric Nephrology, 2011
- Long-term outcome of idiopathic steroid-resistant nephrotic syndrome: a multicenter studyPediatric Nephrology, 2009
- Long-Term Outcome After Cyclophosphamide Treatment in Children With Steroid-Dependent and Frequently Relapsing Minimal Change Nephrotic SyndromeAmerican Journal of Kidney Diseases, 2007
- Mycophenolate Mofetil in Children with Frequently Relapsing Nephrotic SyndromeClinical Journal of the American Society of Nephrology, 2006
- Changes of Lymphocyte Populations in Pediatric Steroid-Sensitive Nephrotic Syndrome Are More Pronounced in Remission than in RelapseAmerican Journal of Nephrology, 2005
- Nephrotic syndrome in childhoodThe Lancet, 2003
- Mycophenolate mofetil in the treatment of resistant idiopathic nephrotic syndromeNephrology Dialysis Transplantation, 2002